Beyond the semi-synthetic artemisinin: metabolic engineering of plant-derived anti-cancer drugs

被引:41
|
作者
Carqueijeiro, Ines [1 ]
Langley, Chloe [2 ]
Grzech, Dagny [2 ]
Koudounas, Konstantinos [1 ]
Papon, Nicolas [3 ]
O'Connor, Sarah E. [2 ]
Courdavault, Vincent [1 ]
机构
[1] Univ Tours, Biomol & Biotechnol Vegetales BBV, EA 2106, Tours, France
[2] Max Planck Inst Chem Ecol, Dept Nat Prod Biosynth, Jena, Germany
[3] UNIV Brest, Grp Etude Interact Hote Pathogene GEIHP, EA 3142, SFR ICAT 4208, Angers, France
基金
欧洲研究理事会; 欧盟地平线“2020”;
关键词
SYNTHETIC BIOLOGY; PATHWAY; YEAST; OPTIMIZATION; COLI;
D O I
10.1016/j.copbio.2019.11.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The discovery and supply of plant-derived anti-cancer compounds remain challenging given their low bioavailability and structural complexity. Reconstituting the pathways of these compounds in heterologous hosts is a promising solution; however, requires the complete elucidation of the biosynthetic genes involved and extensive metabolic engineering to optimise enzyme activity and metabolic flux. This review describes the current strategies and recent advancements in the production of these valuable therapeutic compounds, and highlights plant-derived immunomodulators as an emerging class of anti-cancer agents.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [1] NEW PLANT-DERIVED ANTI-CANCER DRUGS
    KINGHORN, AD
    PHARMACY INTERNATIONAL, 1983, 4 (07): : 191 - 191
  • [2] Preliminary study of anti-cancer activity of semi-synthetic artemisinin derivatives in different cancer cell lines
    Ahmad, F.
    Karna, S.
    Gupta, S.
    Arora, P.
    Shazad, N.
    Pokharel, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S69 - S70
  • [3] Plant-derived EpCAM antigen induces protective anti-cancer response
    Brodzik, R.
    Spitsin, S.
    Golovkin, M.
    Bandurska, K.
    Portocarrero, C.
    Steplewski, Z.
    Koprowski, H.
    Okulicz, M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (03) : 317 - 323
  • [4] Plant-derived EpCAM antigen induces protective anti-cancer response
    Robert Brodzik
    Sergei Spitsin
    Max Golovkin
    Katarzyna Bandurska
    Carla Portocarrero
    Monika Okulicz
    Zenon Steplewski
    Hilary Koprowski
    Cancer Immunology, Immunotherapy, 2008, 57 : 317 - 323
  • [5] Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment
    Zhao, Yuying
    Tan, Hanxu
    Zhang, Juping
    Pan, Bo
    Wang, Neng
    Chen, Tongkai
    Shi, Yafei
    Wang, Zhiyu
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 6847 - 6868
  • [6] Phytochemicals for Cancer Treatment: An Update on Plant-Derived Anti-Cancer Compounds and their Mechanisms of Action
    Ullah, Sana
    Khan, Tariq
    Khan, Taimoor
    Ali, Muhammad
    Jan, Abdul Khaliq
    Shinwari, Zabta Khan
    Khan, Ajmal
    Al-Farsi, Mohamed
    Waqas, Muhammad
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024,
  • [7] Evaluation of plant-derived semi-synthetic molecules against BRD3-BD2 protein: a computational strategy to combat breast cancer
    Kumar, Sachin
    Bhardwaj, Vijay Kumar
    Singh, Rahul
    Das, Pralay
    Purohit, Rituraj
    MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2022, 7 (04) : 381 - 391
  • [8] Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity
    Siambi Kikete
    Li Luo
    Beitian Jia
    Li Wang
    Gregory Ondieki
    Yuhong Bian
    Cytotechnology, 2018, 70 : 1097 - 1110
  • [9] Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology
    Li, Yi
    Pfeifer, Blaine A.
    CURRENT OPINION IN PLANT BIOLOGY, 2014, 19 : 8 - 13
  • [10] Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity
    Kikete, Siambi
    Luo, Li
    Jia, Beitian
    Wang, Li
    Ondieki, Gregory
    Bian, Yuhong
    CYTOTECHNOLOGY, 2018, 70 (04) : 1097 - 1110